Date Filed | Type | Description |
08/10/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
08/10/2023 |
8-K
| Quarterly results |
06/30/2023 |
4
| Campoy Carlos (Director) has filed a Form 4 on Zymeworks Inc.
Txns:
| Granted 50,000 options to buy
@ $8.64, valued at
$432k
|
|
06/30/2023 |
3
| Campoy Carlos (Director) has filed a Form 3 on Zymeworks Inc. |
06/12/2023 |
8-A12B/A
| Form 8-A12B/A - Registration of securities [Section 12(b)]: [Amend] |
06/12/2023 |
8-K
| Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea... |
05/18/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
05/16/2023 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
05/08/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
05/08/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
05/08/2023 |
8-K
| Quarterly results |
05/08/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
05/01/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
04/26/2023 |
8-K
| Quarterly results |
04/18/2023 |
8-K
| Quarterly results |
03/17/2023 |
8-K
| Termination of a Material Definitive Agreement Interactive Data |
03/15/2023 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits ... |
03/14/2023 |
4
| Klompas Neil A (President & COO) has filed a Form 4 on Zymeworks Inc.
Txns:
| Exercised 2,708 restricted stock units
@ $0 Sold 2,977 shares
@ $7.8259, valued at
$23.3k
Exercised 2,500 restricted stock units
@ $0 |
|
03/07/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
03/07/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
03/07/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
03/07/2023 |
POSASR
| Form POSASR - Post-effective Amendment to an automatic shelf registration statement: |
03/07/2023 |
8-K
| Quarterly results |
02/14/2023 |
SC 13G/A
| BAKER BROS. ADVISORS LP reports a 5.9% stake in Zymeworks Inc. |
02/14/2023 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 0% stake in Zymeworks Inc. |
02/14/2023 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 7.2% stake in Zymeworks Inc. |
02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/10/2023 |
SC 13G
| MORGAN STANLEY reports a 8.9% stake in Zymeworks Inc. |
02/02/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
01/23/2023 |
4
| EcoR1 Capital, LLC (10% Owner) has filed a Form 4 on Zymeworks Inc.
Txns:
| Bought 144,100 shares
@ $9.4909, valued at
$1.4M
Bought 163,400 shares
@ $9.8843, valued at
$1.6M
|
|
01/19/2023 |
8-K
| Other Events Interactive Data |
01/18/2023 |
4
| EcoR1 Capital, LLC (10% Owner) has filed a Form 4 on Zymeworks Inc.
Txns:
| Bought 342,100 shares
@ $9.806, valued at
$3.4M
Bought 440,000 shares
@ $9.8042, valued at
$4.3M
Bought 203,000 shares
@ $9.9953, valued at
$2M
|
|
01/12/2023 |
4
| EcoR1 Capital, LLC (10% Owner) has filed a Form 4 on Zymeworks Inc.
Txns:
| Bought 920,000 shares
@ $7.6491, valued at
$7M
Bought 106,300 shares
@ $7.8731, valued at
$836.9k
|
|
01/06/2023 |
4
| Klompas Neil A (President & COO) has filed a Form 4 on Zymeworks Inc.
Txns:
| Granted 87,500 options to buy
@ $8, valued at
$700k
Granted 58,500 restricted stock units
@ $0 |
|
|